Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Alexandros Hadjivasilis"'
Autor:
Costas A. Christophi, Mercedes Sotos-Prieto, Fan-Yun Lan, Mario Delgado-Velandia, Vasilis Efthymiou, Gabriel C. Gaviola, Alexandros Hadjivasilis, Yu-Tien Hsu, Aikaterini Kyprianou, Irene Lidoriki, Chih-Fu Wei, Fernando Rodriguez-Artalejo, Stefanos N. Kales
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Epidemiological studies have yielded conflicting results regarding climate and incident SARS-CoV-2 infection, and seasonality of infection rates is debated. Moreover, few studies have focused on COVD-19 deaths. We studied the association of
Externí odkaz:
https://doaj.org/article/8f3f05246fe6478a8e36b867c54fc94a
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 7 (2020)
Purpose of the review: Validated tools to improve cardiovascular disease (CVD) risk assessment and mortality in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) are lacking. Noninvasive measures of arteriosclerosis and su
Externí odkaz:
https://doaj.org/article/904892307ed94cec913f1c41a60604a6
Autor:
Alexandros Samouilidis, Eleftherios T Beltsios, Georgios Mavrovounis, Antonis Adamou, Ioannis Belios, Alexandros Hadjivasilis, Ioannis Pantazopoulos, Aris P Agouridis
Publikováno v:
Cureus. 14(8)
There are no acceptable worldwide recommendations regarding the use of dexamethasone in late-preterm newborns delivered either vaginally or via cesarean section and term gestation that are performed via cesarean section. The present study aims to com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::911300ca1740112f4b0033987e398704
https://pubmed.ncbi.nlm.nih.gov/36110463
https://pubmed.ncbi.nlm.nih.gov/36110463
Autor:
Vasilis Efthymiou, Stefanos N. Kales, Fan Yun Lan, Aikaterini Kyprianou, Fernando Rodríguez-Artalejo, Alexandros Hadjivasilis, Costas A. Christophi, Yu Tien Hsu, Chih-Fu Wei, Mercedes Sotos-Prieto, Mario Delgado-Velandia, Gabriel C. Gaviola, Irene Lidoriki
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports
Scientific Reports
Background: Epidemiological studies have yielded conflicting results regarding climate and incident SARS-CoV-2 infection, and seasonality of infection rates is debated. Moreover, few studies have focused on COVD-19 deaths. We studied the association
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cf24906fe6cbdaf3da4f5486bf155b2
https://doaj.org/article/8f3f05246fe6478a8e36b867c54fc94a
https://doaj.org/article/8f3f05246fe6478a8e36b867c54fc94a
Autor:
Alexander A. Tzanis, Christos Iavazzo, Alexandros Hadjivasilis, Hara Tsouvali, George Α. Antoniou, Stavros A. Antoniou
Publikováno v:
Oncology reviews. 16
Objective: To investigate whether neoadjuvant chemotherapy (NACT) confers superior outcomes compared to primary debulking surgery (PDS) in patients with stage III and IV epithelial ovarian, tubal or peritoneal cancer as well as in patients with high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a53909cc4da00f0cd048d9e9903a197b
https://pubmed.ncbi.nlm.nih.gov/36531160
https://pubmed.ncbi.nlm.nih.gov/36531160
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 768, p 768 (2022)
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 768
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 768
Aim: Fibrates have proven efficacy in cardiovascular risk reduction and are commonly used, in addition to statins, to control hypertriglyceridaemia. Their use is often limited due to reduction in glomerular filtration rate at treatment initiation. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50f7306cf269b9ebaec2882d7de15c2e
https://www.mdpi.com/2077-0383/11/3/768
https://www.mdpi.com/2077-0383/11/3/768
Autor:
Kalliopi J Ioakim, Panayiotis Kouis, Alexander Tzanis, Alexandros Hadjivasilis, Aris P. Agouridis, Ioanna Poupoutsi
Spontaneous bacterial peritonitis (SBP) is a common complication in patients with cirrhosis and has an incidence of up to 30% in hospitalized patients. Importantly, it may raise their mortality rate up to 30%. Hence, a delayed diagnosis is associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce9aa6cd5d41939399e150a2d155efa0
https://hdl.handle.net/20.500.14279/22866
https://hdl.handle.net/20.500.14279/22866
Background/Objectives: Fibrates reduce cardiovascular risk in the general population and in patients with chronic kidney disease (CKD). Although, they are commonly used as second-line agents in addition to statins for hypertriglyceridemia, their use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfdcb24e52a826fe83ddeed983ac1594
https://doi.org/10.21203/rs.3.rs-104160/v1
https://doi.org/10.21203/rs.3.rs-104160/v1
Publikováno v:
Canadian Journal of Kidney Health and Disease
Canadian Journal of Kidney Health and Disease, Vol 7 (2020)
Canadian Journal of Kidney Health and Disease, Vol 7 (2020)
Validated tools to improve cardiovascular disease (CVD) risk assessment and mortality in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) are lacking. Noninvasive measures of arteriosclerosis and subclinical atheroscleros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77c0d4ddc00be7c4706f909e559ad013
http://europepmc.org/articles/PMC7488604
http://europepmc.org/articles/PMC7488604